ICML 2019 | Immunoepigenetic platforms for PTCL treatment

Owen O’Connor

Owen O’Connor, MD, PhD, Columbia University Medical Center, New York, NY, discusses immunoepigenetic platforms for peripheral T-cell lymphoma (PTCL) treatment and the logic behind using PD-1 inhibitors. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video